Fred Hutch, Seattle Cancer Care Alliance, and UW Medicine Complete Restructure of Partnership

Learn More

Fred Hutch Innovation Lab

Spurring Novel Technology Development and Adoption

In the Fred Hutch Innovation Lab, we are leading the in-house development and early adoption of powerful new research technologies that hold the potential to drive lifesaving discoveries in cancer immunology and other areas of science. 

Our Areas of Focus

graph of cell transcription

Unlocking Secrets of Cell Activity

We are introducing technologies for spatial analysis of single-cell transcription profiling, giving scientists unprecedented insights into cells’ inner workings.

profiling cells under a microscope in a lab

Profiling the Immune System

We are increasing the availability of genetic data and analysis that makes information about the immune system more accessible to all scientists.

Evan Newell reviewing data

Driving Technological Innovation

We are discovering, testing and bringing new technologies online, targeting those of greatest utility for scientists at the vanguard of the promising field of immuno-oncology. 

Our Facilities and Technology Pipeline

Our lab is one of the hallmarks of Fred Hutch’s Steam Plant building, a historic landmark newly redeveloped into a one-of-a-kind facility dedicated to spurring innovation at the nexus of data science and immunology.

There, we use a three-stage pipeline to develop novel technologies for use by the scientific community. First, we test, compare, advance and tailor new technologies that our Advisory Board has selected for their potential to facilitate the next discoveries in immunotherapy. Then, we work with selected researchers to evaluate the technology as they harness it to advance their early-stage research projects. Finally, we make that technology and the protocols and procedures we’ve developed available to researchers across the Hutch to accelerate their science.

Scientific Director

Dr. Evan Newell

Dr. Newell became the scientific director of the Fred Hutch Innovation Lab (FHIL) in January of 2022. He is an immunologist who develops and employs new technologies for accurately identifying specific biological signatures of human health and disease, including cancer and infectious diseases. He and his team work with blood and tissue samples, using mass cytometry and other single-cell analysis methods to better understand how the specificities of immune T cells influence their roles in clinically-productive responses against pathogens or cancers.

Advisory Board

Dr. Phil Bradley

Dr. Phil Bradley

Dr. Lillian Cohn

Dr. Lillian Cohn

Dr. Marion Dorer

Dr. Marion Dorer

Dr. Jeff Delrow

Dr. Jeff Delrow

Dr. Scott Furlan

Dr. Scott Furlan

Dr. Geoffrey Hill

Dr. Geoffrey Hill

Dr. Stan Riddell

Dr. Stan Riddell

Contact Us

Last Modified, April 18, 2022